Athna Biotech is expanding our team! We are seeking talented individuals to join us in advancing innovative therapeutics from discovery to clinical translation.
Athna Biotech, Inc. was awarded a Phase II Small Business Technology Transfer (STTR) grant from the National Institutes of Health (NIH).
Athna Biotech, Inc. was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) to develop a salt-based nanomedicine for non-muscle invasive bladder cancer.
Athna Biotech, Inc. was awarded a Phase I Small Business Technology Transfer (STTR) grant from the National Cancer Institute (NCI) to develop a radiation-activatable nanoparticle therapy for lung cancer.
Athna Biotech, Inc. received its first funding from the Georgia Research Alliance (GRA).
Athna Biotech, Inc. was founded in Athens, Georgia—where our journey began.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.